Role of TNF alpha, in relation to IL-1 and IL-6 in the proteoglycan turnover of human articular cartilage

Br J Rheumatol. 1991 Aug;30(4):265-71. doi: 10.1093/rheumatology/30.4.265.

Abstract

In both young and old human articular cartilage explants, TNF alpha induced a concentration-dependent, reversible suppression of the proteoglycan (PG) synthesis. Young cartilage was more sensitive to TNF alpha than old cartilage: 50% suppression of PG synthesis was reached at a TNF alpha concentration of 5 U/ml for young and 30 U/ml for old cartilage, whereas at 10(3) U/ml the PG synthesis of young cartilage was blocked and that of old cartilage suppressed by 80%. These inhibition levels of PG synthesis resulted in 25% PG depletion of the explants after 8 days of culture. The release of cartilage PG was not enhanced. TNF alpha induced no detectable amounts of IL-1 (less than 0.01 U) in young or old cartilage but did induce IL-6 production. The induced amounts of IL-6 were higher in young than in old cartilage but no dose-dependency was evident. Antibodies to neither IL-1 nor IL-6 had any influence on the TNF alpha-induced suppression of PG synthesis. The combination of TNF alpha and IL-1 led to an additive inhibition of PG synthesis which had no relationship to induced IL-6. TNF alpha was about 100-fold less active than IL-1.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aging / metabolism
  • Cartilage, Articular / metabolism*
  • Culture Media
  • Dose-Response Relationship, Drug
  • Humans
  • Interleukin-1 / metabolism*
  • Interleukin-6 / metabolism*
  • Proteoglycans / antagonists & inhibitors
  • Proteoglycans / metabolism*
  • Recombinant Proteins
  • Tumor Necrosis Factor-alpha / pharmacology
  • Tumor Necrosis Factor-alpha / physiology*

Substances

  • Culture Media
  • Interleukin-1
  • Interleukin-6
  • Proteoglycans
  • Recombinant Proteins
  • Tumor Necrosis Factor-alpha